CAS 942142-51-0: methyl (2-{(R)-(3-chlorophenyl)[(3R)-1-({(2S)-2-(methylamino)-3-[(3R)-tetrahydro-2H-pyran-3-yl]propyl}carbamoyl)piperidin-3-yl]methoxy}ethyl)carbamate

Applications VTP 27999, is a new renin inhibitor, that alters renin immunoreactivity and does not unfold prorenin. References Manne, K., et al.: Hypertension, 61, 1075 (2013);

Applications VTP 27999-d3, is the labeled analogue of VTP 27999 (V785050), which is a new renin inhibitor, that alters renin immunoreactivity and does not unfold prorenin. References Manne, K., et al.: Hypertension, 61, 1075 (2013);

Carbamic acid,n-[2-[(R)-(3-chlorophenyl)[(3R)-1-[[[(2S)-2-(methylamino)-3-[(3R)-tetrahydro-2H-pyran-3-yl]propyl]amino]carbonyl]-3-pi peridinyl]methoxy]ethyl]-,methylester is a potent and selective inhibitor of the protein target, human DNA polymerase α. It has been shown to inhibit the growth of cancer cells in vitro and in vivo. Carbamic acid,n-[2-[(R)-(3-chlorophenyl)[(3R)-1-[[[(2S)-2-(methylamino)-3-[(3R)-tetrahydro-2H-pyran-3-yl]propyl]amino]carbonyl]-3-pi peridinyl]m

VTP-27999 is an alkyl amine Renin inhibitor. VTP-27999 has been used in trials studying the basic science of Renal Function.